Publicaciones en las que colabora con Eduardo Collantes Estévez (29)

2024

  1. Exploring candidate biomarkers for rheumatoid arthritis through cardiovascular and cardiometabolic serum proteome profiling

    Frontiers in Immunology, Vol. 15

2023

  1. Clinical features and immune mechanisms directly linked to the altered liver function in patients with rheumatoid arthritis

    European Journal of Internal Medicine, Vol. 118, pp. 49-58

2021

  1. Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

    Arthritis and Rheumatology, Vol. 73, Núm. 6, pp. 1073-1085

2019

  1. Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x)

    Pharmacogenomics Journal

  2. Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients

    Pharmacogenomics Journal, Vol. 19, Núm. 1, pp. 83-96

  3. Recommendations for the prescription of physical exercise for patients with spondyloarthritis

    Reumatologia Clinica, Vol. 15, Núm. 2, pp. 77-83

  4. Steroid hormone-related polymorphisms associate with the development of bone erosions in rheumatoid arthritis and help to predict disease progression: Results from the REPAIR consortium

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. High reproducibility of an automated measurement of mobility for patients with axial spondyloarthritis

    Journal of Rheumatology, Vol. 45, Núm. 10, pp. 1383-1388

2017

  1. Disease Activity As a Major Determinant of Quality of Life and Physical Function in Patients With Early Axial Spondyloarthritis

    Arthritis Care and Research, Vol. 69, Núm. 1, pp. 150-155

  2. Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain

    Rheumatology International, Vol. 37, Núm. 8, pp. 1239-1248

2016

  1. Evaluation of the impact of nursing clinics in the rheumatology services

    Rheumatology International, Vol. 36, Núm. 9, pp. 1309-1317

2015

  1. Is spinal mobility in patients with spondylitis determined by age, structural damage, and inflammation?

    Arthritis Care and Research, Vol. 67, Núm. 1, pp. 74-79

  2. Recomendaciones para la detección, investigación y derivación del dolor lumbar inflamatorio en Atención Primaria

    Reumatologia Clinica, Vol. 11, Núm. 2, pp. 90-98

2014

  1. Performance of the Assessment of Spondyloarthritis International Society criteria for the classification of spondyloarthritis in early spondyloarthritis clinics participating in the ESPERANZA programme

    Rheumatology (United Kingdom), Vol. 53, Núm. 2, pp. 353-360

  2. Validation of a new objective index to measure spinal mobility: The University of Cordoba Ankylosing Spondylitis Metrology Index (UCOASMI)

    Rheumatology International, Vol. 34, Núm. 3, pp. 401-406

  3. Validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme

    Annals of the Rheumatic Diseases, Vol. 73, Núm. 7, pp. 1350-1355

2013

  1. Diferente expresión clínica de los pacientes con espondilitis anquilosante según el sexo en función del tiempo de evolución. Datos de REGISPONSER

    Reumatologia Clinica, Vol. 9, Núm. 4, pp. 221-225

  2. Gender-Specific Effects of Genetic Variants within Th1 and Th17 Cell-Mediated Immune Response Genes on the Risk of Developing Rheumatoid Arthritis

    PLoS ONE, Vol. 8, Núm. 8

  3. Orthopedic surgery in rheumatoid arthritis in the era of biologic therapy

    Journal of Rheumatology, Vol. 40, Núm. 11, pp. 1850-1855

2011

  1. A model for the development and implementation of a national plan for the optimal management of early spondyloarthritis: The Esperanza Program

    Annals of the Rheumatic Diseases, Vol. 70, Núm. 5, pp. 827-830